Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet vs Parathyroidectomy in Peritoneal Dialysis Patients with SHPT
NCT01447368Phase 4Completed
- Sponsor
- The University of Hong Kong
- Start
- May 2010
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cinacalcet in secondary hyperparathyroidism (SHPT) (2 arms), sponsored by The University of Hong Kong. Primary endpoints: Change in coronary artery calcium score at 52 weeks and Change in left ventricular mass index at 52 weeks. Started May 2010; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT01447368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01447368.